梯瓦制药(TEVA.N)美国存托凭证涨幅扩大至19%,公司此前与赛诺菲(SNY.O)宣布Duvakitug药物的试验结果,达到治疗溃疡性结肠炎和克罗恩病的主要终点。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.